Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
954 studies found for:    Open Studies | "Pancreatic Diseases"
Show Display Options
Rank Status Study
21 Recruiting Studying Patients With Cystic Fibrosis and Other Pulmonary and Pancreatic Disorders
Condition: Cystic Fibrosis
22 Recruiting Pancreas Registry and High Risk Registry
Conditions: Pancreas Cancer;   Pancreatitis;   Chronic Pancreatitis;   Pancreatic Cyst;   Family History of Pancreas Cancer;   Genetic Mutations
23 Unknown  Computer Tools for Improving Early Diagnosis and Treatment in Healthy Volunteers or Patients With Pancreatic Cancer or Who Are At Risk For Pancreatic Cancer or Who Have a Noncancer Pancreatic Disorder
Condition: Pancreatic Cancer
Interventions: Other: medical chart review;   Other: questionnaire administration;   Other: study of socioeconomic and demographic variables;   Procedure: biopsy
24 Recruiting Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Exploratory Efficacy Parameters of AIR DNase™in Patients With Cystic Fibrosis Previously Treated With Pulmozyme®
Condition: Cystic Fibrosis
Intervention: Drug: AIR DNase™
25 Recruiting Saline Hypertonic in Preschoolers
Condition: Cystic Fibrosis
Interventions: Drug: 7% Hypertonic Saline (HS);   Drug: 0.9% Isotonic Saline (IS)
26 Recruiting A Study of BBI608 in Combination With Standard Chemotherapies in Adult Patients With Pancreatic Cancer
Condition: Metastatic Pancreatic Adenocarcinoma
Interventions: Drug: BBI608;   Drug: Nab-paclitaxel;   Drug: Gemcitabine;   Drug: Oxaliplatin;   Drug: Leucovorin;   Drug: Irinotecan;   Drug: Fluorouracil;   Drug: MM-398
27 Recruiting Follow-up Study of Complications of Acute Pancreatitis
Conditions: Pancreatitis;   Pancreatic Neoplasms;   Metabolic Diseases;   Hypertension, Portal;   Respiratory Failure;   Quality of Life
28 Not yet recruiting Enhancing Fitness Before Pancreatic Surgery
Conditions: Pancreatic Cancer;   Pancreatitis, Chronic
Intervention: Other: MedEx
29 Recruiting CSI-Glucagon for Prevention of Hypoglycemia in Children With Congenital Hyperinsulinism
Condition: Congenital Hyperinsulinism
Interventions: Drug: Glucagon;   Other: Placebo
30 Recruiting Circulating Cell-free Tumor DNA(ctDNA) in Pancreatic Cancer
Condition: Pancreatic Cancer
31 Recruiting MAD Study Evaluating the Safety, Tolerability, and Pharmacokinetics of N91115 in Healthy Subjects (SNO-9)
Condition: Cystic Fibrosis
Interventions: Drug: N91115;   Other: Placebo
32 Not yet recruiting Perceived Impact of Art Therapy in Patients With Cystic Fibrosis and in Professional Interdisciplinary Teams Taking Care of Them.
Condition: Cystic Fibrosis
Intervention: Other: Non interventional study
33 Not yet recruiting Preoperative Pilot Study to Assess Safety and Immunological Effect of Pembrolizumab (Keytruda®) in Combination With Paricalcitol With or Without Chemotherapy in Patients With Resectable Pancreatic Cancer
Condition: Pancreatic Cancer
Interventions: Drug: Pembrolizumab;   Drug: Paricalcitol;   Drug: Gemcitabine;   Drug: Nab-paclitaxel;   Procedure: Surgical Resection
34 Recruiting Immunotherapy of CD8+NKG2D+ AKT Cell With Chemotherapy to Pancreatic Cancer
Condition: Pancreatic Ductal Adenocarcinoma
Interventions: Biological: CD8+NKG2D+ AKT Cell;   Drug: Gemcitabine
35 Recruiting A Clinical Study on the Efficacy and Safety of the Treatment of Hyperplasia of Mammary Glands With Xiaoru Sanjie Capsule
Condition: Fibrocystic Disease of Breast
Interventions: Drug: Xiaoru Sanjie capsules;   Drug: Xiao Yao pills
36 Recruiting The Association Between Post-ERCP Acute Pancreatitis and Various Genetic Mutations
Condition: Acute Pancreatitis
Intervention: Procedure: ERCP
37 Recruiting Standard Versus Extended Lymphadenectomy in Pancreatoduodenectomy for Patients With Pancreatic Head Adenocarcinoma
Condition: Carcinoma, Pancreatic Ductal
Interventions: Procedure: Extended lymphadenectomy;   Procedure: Standard lymphadenectomy
38 Not yet recruiting Quality of Life After in Situ IRE in Locally Advanced Pancreatic Cancer
Condition: Pancreatic Cancer
Intervention: Procedure: Irreversible electroporation
39 Not yet recruiting Study of AM0010 With FOLFOX Compared to FOLFOX Alone Second-line Tx in Pts With Metastatic Pancreatic Cancer
Condition: Pancreatic Cancer
Interventions: Biological: AM0010;   Drug: FOLFOX
40 Not yet recruiting TAS-102 (Lonsurf) in Metastatic or Locally Advanced Unresectable Pancreatic Adenocarcinoma Post First Line Chemotherapy
Condition: Pancreatic Cancer
Intervention: Drug: TAS-102

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years